Distribution and Development Agreement Sample Contracts

Standard Contracts

WITNESSETH
Distribution and Development Agreement • November 19th, 2004 • Stentor Inc • California
AutoNDA by SimpleDocs
Amendment to Distribution and Development Agreement
Distribution and Development Agreement • August 13th, 2021 • Qualigen Therapeutics, Inc. • Pharmaceutical preparations

This Amendment to Distribution and Development Agreement (this “Amendment”) is entered into by and between Sekisui Diagnostics, LLC, a Delaware limited liability company (“Sekisui”), and Qualigen, Inc., a Delaware corporation (“Qualigen”), as of July 1, 2021. This Amendment amends that certain Distribution and Development Agreement dated May 1, 2016 between Sekisui and Qualigen (as amended to the date hereof, the “Distribution and Development Agreement”).

Buffalo Turbine Partners with Clarke in Distribution and Development Agreement
Distribution and Development Agreement • October 14th, 2016

Buffalo Turbine of Springville, NY has entered into a distribution and development agreement with Clarke, the public health mosquito control company based in St. Charles, IL.

Amendment to Distribution and Development Agreement
Distribution and Development Agreement • March 13th, 2020 • Ritter Pharmaceuticals Inc • Pharmaceutical preparations

This Amendment to Distribution and Development Agreement (this “Amendment”) is entered into by and between Sekisui Diagnostics, LLC, a Delaware limited liability company (“Sekisui”), and Qualigen, Inc., a Delaware corporation (“Qualigen”), and shall be effective as of April 2, 2018. This Amendment amends that certain Distribution and Development Agreement dated May 1, 2016 between Sekisui and Qualigen, as amended to the date hereof (collectively, the “Distribution and Development Agreement”).

Distribution and Development Agreement for Ciclesonide in the USA By and between Nycomed GmbH (formerly known as ALTANA Pharma AG) Byk Gulden-Strasse 2 78467 Konstanz Federal Republic of Germany and Sepracor Inc. 84 Waterford Drive Marlborough, MA...
Distribution and Development Agreement • February 29th, 2008 • Sepracor Inc /De/ • Pharmaceutical preparations

This Distribution and Development Agreement relating to the pharmaceutical compound ciclesonide, dated this January 25th, 2008 is being entered into by and between Nycomed GmbH (formerly known as ALTANA Pharma AG), a corporation organized and existing under the laws of Germany and having its principal office at Byk-Gulden-Strasse 2, 78467 Konstanz, Federal Republic of Germany ("Nycomed"), and Sepracor Inc., a corporation organized and existing under the laws of the state of Delaware and having its principal office at 84 Waterford Drive, Marlborough, MA 01752, USA ("Sepracor"). Each or both of Nycomed and Sepracor are hereinafter referred to as "Party" or "Parties", as intended in the given context.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!